Trial Profile
A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Versus Placebo as Adjunct Therapy With Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients With Bipolar I Disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Alcoholism; Bipolar I disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 11 Sep 2008 New trial record.